Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside

N/A

Report date: 2025/11/26 17:11:09
NME

Base Information

Drug NameAlpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside
Drug Alias Namea-methyl-4[18F]-4-deoxy-D-glucopyranosideAlpha-methyl-4-[F-18]-fluoro-4-deoxy-d-glucopyranosideMe-4(18F)DGMe-4FDGMe4FDG +[6] 
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18F
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsAdenocarcinoma of Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of ViennaUclas Jonsson Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesUclas Jonsson Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsAdenocarcinoma of Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A